PVH
ALNY icon

Psagot Value Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Psagot Value Holdings’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8
Closed -$1K – 346
2022
Q2 		$1K Hold
8
– – ﹤0.01% 289
2022
Q1 		$1K Buy
8
+1
+14% +$152 ﹤0.01% 319
2021
Q4 		$1K Sell
7
-3
-30% -$558 ﹤0.01% 344
2021
Q3 		$2K Buy
+10
New +$1.88K ﹤0.01% 393

Other funds holding ALNY

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Psagot Value Holdings's ALNY Position: Q3 2022 in Review

Psagot Value Holdings sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2022, closing a stake of 8 shares — an estimated $1K sold.

Psagot Value Holdings first reported a position in ALNY in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 497 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.

  • Psagot Value Holdings reported no remaining Alnylam Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Psagot Value Holdings sold 8 Alnylam Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Psagot Value Holdings first reported a position in Alnylam Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Psagot Value Holdings's Alnylam Pharmaceuticals position peaked at $2K in Q3 2021.
  • 497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.

Based on Psagot Value Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.